Article Information
History
- April 4, 2021.
Article Versions
- You are currently viewing Version 1 of this article (April 4, 2021 - 12:24).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- aDepartment of Chemistry, Stony Brook University, Stony Brook, NY 11794-3400
- bChronus Pharmaceuticals, Inc., 25 Health Sciences Drive, Stony Brook, NY 11790
- cClinical and Translational Science Center, Weill Cornell Medicine, New York, NY 10065
- dDepartment of Pediatrics, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY 11794-3400
- ↵#Corresponding author: nicole.sampson{at}stonybrook.edu
Posted April 04, 2021.
Retrospective feasibility study of Mycobacterium tuberculosis modified lipoprotein as a potential biomarker for TB detection in children
